[1]
H. Ahmed, S. Gomaa, M. Alazzeh, M. Darwish, M. K. Mansour, and J. Lauchner, “Sodium-Glucose Cotransporter-2 Inhibitors Are Associated with Improved Survival in Patients with Cirrhosis”, JGLD, vol. 35, no. 2, pp. 222–228, Jun. 2026.